news
06-13-2023, 03:06 PM
First Vaccine For Chikungunya—An Emerging Mosquito-Borne Threat—Nears After Promising Trial Results (https://news.google.com/rss/articles/CBMilwFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL3JvYm VydGhhcnQvMjAyMy8wNi8xMi9maXJzdC12YWNjaW5lLWZvci1j aGlrdW5ndW55YS1hbi1lbWVyZ2luZy1tb3NxdWl0by1ib3JuZS 10aHJlYXQtbmVhcnMtYWZ0ZXItcHJvbWlzaW5nLXRyaWFsLXJl c3VsdHMv0gGbAWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZX Mvcm9iZXJ0aGFydC8yMDIzLzA2LzEyL2ZpcnN0LXZhY2NpbmUt Zm9yLWNoaWt1bmd1bnlhLWFuLWVtZXJnaW5nLW1vc3F1aXRvLW Jvcm5lLXRocmVhdC1uZWFycy1hZnRlci1wcm9taXNpbmctdHJp YWwtcmVzdWx0cy9hbXAv?oc=5) Forbes
First phase 3 trial of a chikungunya vaccine candidate finds it is generally safe and provokes an immune response (https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vbWVkaWNhbHhwcmVzcy5jb20vbmV3cy8yMD IzLTA2LXBoYXNlLXRyaWFsLWNoaWt1bmd1bnlhLXZhY2NpbmUt Y2FuZGlkYXRlLmh0bWzSAVRodHRwczovL21lZGljYWx4cHJlc3 MuY29tL25ld3MvMjAyMy0wNi1waGFzZS10cmlhbC1jaGlrdW5n dW55YS12YWNjaW5lLWNhbmRpZGF0ZS5hbXA?oc=5) Medical Xpress
First-ever, single-shot Chikungunya vaccine shows positive results: Study (https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3Lndpb25ld3MuY29tL3NjaWVuY2UvZm lyc3QtZXZlci1zaW5nbGUtc2hvdC1jaGlrdW5ndW55YS12YWNj aW5lLXNob3dzLXBvc2l0aXZlLXJlc3VsdHMtc3R1ZHktNjA0MD M40gFyaHR0cHM6Ly93d3cud2lvbmV3cy5jb20vc2NpZW5jZS9m aXJzdC1ldmVyLXNpbmdsZS1zaG90LWNoaWt1bmd1bnlhLXZhY2 NpbmUtc2hvd3MtcG9zaXRpdmUtcmVzdWx0cy1zdHVkeS02MDQw MzgvYW1w?oc=5) WION
Positive Results For Potential First Chikungunya Vaccine (https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3Lm5kdHYuY29tL3dvcmxkLW5ld3MvcG 9zaXRpdmUtcmVzdWx0cy1mb3ItcG90ZW50aWFsLWZpcnN0LWNo aWt1bmd1bnlhLXZhY2NpbmUtNDExNzIzMNIBZmh0dHBzOi8vd3 d3Lm5kdHYuY29tL3dvcmxkLW5ld3MvcG9zaXRpdmUtcmVzdWx0 cy1mb3ItcG90ZW50aWFsLWZpcnN0LWNoaWt1bmd1bnlhLXZhY2 NpbmUtNDExNzIzMC9hbXAvMQ?oc=5) NDTV
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial (https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LnRoZWxhbmNldC5jb20vam91cm5hbH MvbGFuY2V0L2FydGljbGUvUElJUzAxNDAtNjczNigyMykwMDY0 MS00L2Z1bGx0ZXh00gEA?oc=5) The Lancet
View Full Coverage on Google News (https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2p1eV pqNkJ4Rk05QVlIWDg5cF9TZ0FQAQ?hl=en-US&gl=US&ceid=US:en&oc=5)
More... (https://news.google.com/rss/articles/CBMilwFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL3JvYm VydGhhcnQvMjAyMy8wNi8xMi9maXJzdC12YWNjaW5lLWZvci1j aGlrdW5ndW55YS1hbi1lbWVyZ2luZy1tb3NxdWl0by1ib3JuZS 10aHJlYXQtbmVhcnMtYWZ0ZXItcHJvbWlzaW5nLXRyaWFsLXJl c3VsdHMv0gGbAWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZX Mvcm9iZXJ0aGFydC8yMDIzLzA2LzEyL2ZpcnN0LXZhY2NpbmUt Zm9yLWNoaWt1bmd1bnlhLWFuLWVtZXJnaW5nLW1vc3F1aXRvLW Jvcm5lLXRocmVhdC1uZWFycy1hZnRlci1wcm9taXNpbmctdHJp YWwtcmVzdWx0cy9hbXAv?oc=5)
First phase 3 trial of a chikungunya vaccine candidate finds it is generally safe and provokes an immune response (https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vbWVkaWNhbHhwcmVzcy5jb20vbmV3cy8yMD IzLTA2LXBoYXNlLXRyaWFsLWNoaWt1bmd1bnlhLXZhY2NpbmUt Y2FuZGlkYXRlLmh0bWzSAVRodHRwczovL21lZGljYWx4cHJlc3 MuY29tL25ld3MvMjAyMy0wNi1waGFzZS10cmlhbC1jaGlrdW5n dW55YS12YWNjaW5lLWNhbmRpZGF0ZS5hbXA?oc=5) Medical Xpress
First-ever, single-shot Chikungunya vaccine shows positive results: Study (https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3Lndpb25ld3MuY29tL3NjaWVuY2UvZm lyc3QtZXZlci1zaW5nbGUtc2hvdC1jaGlrdW5ndW55YS12YWNj aW5lLXNob3dzLXBvc2l0aXZlLXJlc3VsdHMtc3R1ZHktNjA0MD M40gFyaHR0cHM6Ly93d3cud2lvbmV3cy5jb20vc2NpZW5jZS9m aXJzdC1ldmVyLXNpbmdsZS1zaG90LWNoaWt1bmd1bnlhLXZhY2 NpbmUtc2hvd3MtcG9zaXRpdmUtcmVzdWx0cy1zdHVkeS02MDQw MzgvYW1w?oc=5) WION
Positive Results For Potential First Chikungunya Vaccine (https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3Lm5kdHYuY29tL3dvcmxkLW5ld3MvcG 9zaXRpdmUtcmVzdWx0cy1mb3ItcG90ZW50aWFsLWZpcnN0LWNo aWt1bmd1bnlhLXZhY2NpbmUtNDExNzIzMNIBZmh0dHBzOi8vd3 d3Lm5kdHYuY29tL3dvcmxkLW5ld3MvcG9zaXRpdmUtcmVzdWx0 cy1mb3ItcG90ZW50aWFsLWZpcnN0LWNoaWt1bmd1bnlhLXZhY2 NpbmUtNDExNzIzMC9hbXAvMQ?oc=5) NDTV
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial (https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LnRoZWxhbmNldC5jb20vam91cm5hbH MvbGFuY2V0L2FydGljbGUvUElJUzAxNDAtNjczNigyMykwMDY0 MS00L2Z1bGx0ZXh00gEA?oc=5) The Lancet
View Full Coverage on Google News (https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2p1eV pqNkJ4Rk05QVlIWDg5cF9TZ0FQAQ?hl=en-US&gl=US&ceid=US:en&oc=5)
More... (https://news.google.com/rss/articles/CBMilwFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL3JvYm VydGhhcnQvMjAyMy8wNi8xMi9maXJzdC12YWNjaW5lLWZvci1j aGlrdW5ndW55YS1hbi1lbWVyZ2luZy1tb3NxdWl0by1ib3JuZS 10aHJlYXQtbmVhcnMtYWZ0ZXItcHJvbWlzaW5nLXRyaWFsLXJl c3VsdHMv0gGbAWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZX Mvcm9iZXJ0aGFydC8yMDIzLzA2LzEyL2ZpcnN0LXZhY2NpbmUt Zm9yLWNoaWt1bmd1bnlhLWFuLWVtZXJnaW5nLW1vc3F1aXRvLW Jvcm5lLXRocmVhdC1uZWFycy1hZnRlci1wcm9taXNpbmctdHJp YWwtcmVzdWx0cy9hbXAv?oc=5)